BSE
506197

Bliss GVS Pharma Limited

Drug Manufacturers - Major
Healthcare

Prices are adjusted according to historical splits.

Bliss GVS Pharma Limited Stock Price

Vitals

Today's Low:
₹90.35
Today's High:
₹96.27
Open Price:
₹96
52W Low:
₹68.1609
52W High:
₹103.9
Prev. Close:
₹95.47
Volume:
45557

Company Statistics

Market Cap.:
₹17.97 billion
Book Value:
74.528
Revenue TTM:
₹5.49 billion
Operating Margin TTM:
15.63%
Gross Profit TTM:
₹2.43 billion
Profit Margin:
12.61%
Return on Assets TTM:
5.21%
Return on Equity TTM:
9.24%

Company Profile

Bliss GVS Pharma Limited had its IPO on under the ticker symbol 506197.

The company operates in the Healthcare sector and Drug Manufacturers - Major industry. Bliss GVS Pharma Limited has a staff strength of 0 employees.

Stock update

Shares of Bliss GVS Pharma Limited opened at ₹96 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹90.35 - ₹96.27, and closed at ₹91.23.

This is a -4.44% slip from the previous day's closing price.

A total volume of 45,557 shares were traded at the close of the day’s session.

In the last one week, shares of Bliss GVS Pharma Limited have slipped by -5.71%.

Bliss GVS Pharma Limited's Key Ratios

Bliss GVS Pharma Limited has a market cap of ₹17.97 billion, indicating a price to book ratio of 2.1906 and a price to sales ratio of 3.1425.

In the last 12-months Bliss GVS Pharma Limited’s revenue was ₹5.49 billion with a gross profit of ₹2.43 billion and an EBITDA of ₹982.41 million. The EBITDA ratio measures Bliss GVS Pharma Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Bliss GVS Pharma Limited’s operating margin was 15.63% while its return on assets stood at 5.21% with a return of equity of 9.24%.

In Q3, Bliss GVS Pharma Limited’s quarterly earnings growth was a negative -35% while revenue growth was a negative 27.9%.

Bliss GVS Pharma Limited’s PE and PEG Ratio

Forward PE
0
Trailing PE
24.6003
PEG

Its diluted EPS in the last 12-months stands at ₹6.634 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bliss GVS Pharma Limited’s profitability.

Bliss GVS Pharma Limited stock is trading at a EV to sales ratio of 3.1011 and a EV to EBITDA ratio of 14.2011. Its price to sales ratio in the trailing 12-months stood at 3.1425.

Bliss GVS Pharma Limited stock pays annual dividends of ₹0.5 per share, indicating a yield of 0.31% and a payout ratio of 7.53%.

Balance sheet and cash flow metrics

Total Assets
₹11.57 billion
Total Liabilities
₹1.93 billion
Operating Cash Flow
₹-77509000.00
Capital Expenditure
₹937.99 million
Dividend Payout Ratio
7.53%

Bliss GVS Pharma Limited ended 2024 with ₹11.57 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹11.57 billion while shareholder equity stood at ₹8.84 billion.

Bliss GVS Pharma Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.93 billion in other current liabilities, 104153000.00 in common stock, ₹0 in retained earnings and ₹77.11 million in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹1.12 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹406.90 million.

Bliss GVS Pharma Limited’s total current assets stands at ₹6.97 billion while long-term investments were ₹0 and short-term investments were ₹91.70 million. Its net receivables were ₹3.85 billion compared to accounts payable of ₹0 and inventory worth ₹1.03 billion.

In 2024, Bliss GVS Pharma Limited's operating cash flow was ₹-77509000.00 while its capital expenditure stood at ₹937.99 million.

Comparatively, Bliss GVS Pharma Limited paid ₹0.08 in dividends in 2024.

Other key metrics

Current Trading Price
₹91.23
52-Week High
₹103.9
52-Week Low
₹68.1609
Analyst Target Price

Bliss GVS Pharma Limited stock is currently trading at ₹91.23 per share. It touched a 52-week high of ₹103.9 and a 52-week low of ₹103.9. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹93.01 and 200-day moving average was ₹79.23 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 7006.6% of the company’s stock are held by insiders while 1043.5% are held by institutions.

Frequently Asked Questions About Bliss GVS Pharma Limited

The stock symbol (also called stock or share ticker) of Bliss GVS Pharma Limited is 506197

The IPO of Bliss GVS Pharma Limited took place on

Similar Industry Stocks (Drug Manufacturers - Major)

Last Price
Chg
Chg%
₹33.56
-0.07
-0.21%
₹26.74
-0.14
-0.52%
₹50.38
-1.17
-2.27%
₹39.88
0.43
+1.09%
Moderna Inc (MRNA)
₹105.24
-0.56
-0.53%
₹39.91
0.24
+0.61%
Zoetis Inc (ZTS)
₹187.7
1.63
+0.88%
Nava Limited (513023)
₹394.05
-24.85
-5.93%
₹1.83
-0
-0.11%
₹11.85
0.03
+0.25%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
₹0.14
0.07
+100%
₹0.12
0.04
+45.29%
₹0.96
0.05
+5.4%
₹1.34
-0.35
-20.71%
Humbl Inc (HMBL)
₹0
0
0%

Top Gainers

Last Price
Chg
Chg%
₹0
0
+172200%
₹0
0
+51200%
₹283
280.03
+9428.62%
₹11.2
10.57
+1667.68%
Latch Inc (LTCHW)
₹0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
₹0.19
-123.15
-99.85%
₹0
-0.11
-99.55%
₹0
-0
-97.96%
₹0
-0.01
-93.94%
₹0.01
-0.06
-92.24%

About

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. The company offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. It also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, the company offers therapeutic products consisting of anti-bacterial, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. It also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Address

102, Hyde Park, Mumbai, India, 400072